Wells Fargo lowered the firm’s price target on Bath & Body Works to $25 from $33 and keeps an Overweight rating on the shares. The firm says the anticipated reset to numbers finally happened. Bears will continue to argue for further downside. However, with Q4 guided down and called out several times as “the floor” on fundamentals, Wells sees 2026 as de-risked, with setup much more compelling.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBWI:
- Bath & Body downgraded to Market Perform from Outperform at Telsey Advisory
- Bath & Body Works price target lowered to $18 from $28 at Barclays
- Challenges Ahead: Bath & Body Works Faces Structural Headwinds and Downgrade
- Bath & Body Works downgraded to Equal Weight from Overweight at Morgan Stanley
- Bath & Body Works Unveils Strategic Growth Plan